Press release
Surging Prevalence Of Chronic Kidney Diseases Sparks Growth In The Late-Stage CKD Drug Market
Late Stage Chronic Kidney Disease Drugs Market Size
What Is the Late Stage Chronic Kidney Disease Drugs Market Size and Projected Growth Rate?
The market size for drugs treating late stage chronic kidney disease has undergone rapid expansion in the past few years. It is projected to rise from $7.08 billion in 2024 to $7.92 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 11.9%. Factors contributing to the historic period's growth include enhanced diagnostic services, an aging society, increased incidences of diabetes and hypertension, increased awareness about kidney diseases, and the development and expansion of pharmaceutical research.
Over the coming years, the market for drugs targeted at late-stage chronic kidney disease is expected to experience significant growth. Forecasts indicate that it will increase to a value of $12.2 billion by 2029, boasting a compound annual growth rate (CAGR) of 11.4%. The known causes for this growth during the forecast period are increased spending on healthcare, the implementation of precision medicine tactics, a growing focus on regenerative medicine, an increased emphasis on care that prioritizes patients, and global campaigns to raise awareness of kidney disease. Key trends for this forecast period comprise the enhancement of regenerative medicine therapies, a surge in the use of telemedicine services for managing CKD, the creation of combined therapies, focus on early intervention methods, and a rising interest in diagnostics based on biomarkers.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12196
What Are the Major Segments in the Late Stage Chronic Kidney Disease Drugs Market?
The late stage chronic kidney disease drugs market covered in this report is segmented -
1) By Product Type: Calcimimetics, Vitamin D, Sterols, Potassium Binders, Calcium-Based Phosphate Binders
2) By Indication Type: Late Stage Chronic Kidney Disease Induced Hyperparathyroidism, Late Stage Chronic Kidney Disease Induced Hyperphosphatemia, Late Stage Chronic Kidney Disease Induced Hyperkalemia
3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
Subsegments:
1) By Calcimimetics: Cinacalcet, Etelcalcetide
2) By Vitamin D: Calcitriol, Doxercalciferol, Paricalcitol
3) By Sterols: Ergocalciferol, Cholecalciferol
4) By Potassium Binders: Sodium Polystyrene Sulfonate, Patiromer, Sodium Zirconium Cyclosilicate
5) By Calcium-Based Phosphate Binders: Calcium Acetate, Calcium Carbonate
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12196&type=smp
What Are The Driving Late Stage Chronic Kidney Disease Drugs Market Evolution?
The escalating occurrence of chronic kidney diseases is anticipated to stimulate the expansion of the late-stage chronic kidney disease drug market. Chronic kidney diseases denote a variety of conditions impacting the functionality and form of the kidneys. Late-stage chronic kidney disease drugs are leveraged to manage blood pressure levels in patients and minimize protein loss, thereby retarding the progression of kidney deterioration, managing symptoms, and averting consequences. For instance, the Centers for Disease Control and Prevention (CDC), an American public health institution, reported in May 2024 that approximately 14% or a staggering 35.5 million adults in the U.S. are thought to be suffering from chronic kidney diseases. Hence, the high occurrence of chronic kidney disease is fuelling the expansion of the late-stage chronic kidney disease drug market.
Which Firms Dominate The Late Stage Chronic Kidney Disease Drugs Market Segments?
Major companies operating in the late stage chronic kidney disease drugs market include Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca plc, Eli Lilly and Company, C.H. Boehringer Sohn AG & Co. KG, Amgen Inc., Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Takeda Pharmaceutical Company Limited, Kyowa Kirin Co Ltd., OPKO Health Inc., Evotec SE, Ionis Pharmaceuticals Inc., Akebia Therapeutics Inc., Ardelyx Inc., Concert Pharmaceuticals Inc., Pharmaxis Limited, Deltanoid Pharmaceuticals Inc., Liminal BioSciences Inc., Chinook Therapeutics Inc., Allena Pharmaceuticals Inc, Shield Therapeutics Plc
What Trends Are Expected to Dominate the Late Stage Chronic Kidney Disease Drugs Market in the Next 5 Years?
In the late-stage chronic kidney disease drug market, product innovation is emerging as a critical trend. Major market players are creating new drug products to maintain their market status. For instance, Bayer, a pharmaceutical and biotechnology company based in Germany, introduced Kerendia (finerenone) in India in February 2022. This first-of-its-kind non-steroidal, selective mineralocorticoid receptor antagonist is intended for patients suffering from type two diabetes and chronic renal disease. Finerenone operates by blocking the overactivation of the mineralocorticoid receptor (MR), considered to play a role in CKD development and cardiovascular harm.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/late-stage-chronic-kidney-disease-drugs-global-market-report
Which Is The Largest Region In The Late Stage Chronic Kidney Disease Drugs Market?
North America was the largest region in the late-stage chronic kidney disease drugs market in 2024. The regions covered in the late-stage chronic kidney disease drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Late Stage Chronic Kidney Disease Drugs Market?
2. What is the CAGR expected in the Late Stage Chronic Kidney Disease Drugs Market?
3. What Are the Key Innovations Transforming the Late Stage Chronic Kidney Disease Drugs Industry?
4. Which Region Is Leading the Late Stage Chronic Kidney Disease Drugs Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Surging Prevalence Of Chronic Kidney Diseases Sparks Growth In The Late-Stage CKD Drug Market here
News-ID: 3999423 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Late
Late Night Revelry Awaits at The Winslow Lounge - NYC's Premier Late-Night Desti …
Image: https://www.getnews.info/wp-content/uploads/2024/06/1713864312.jpeg
New York, NY - The Winslow Lounge, located in the heart of the East Village, has quickly become the premier late-night destination [https://thewinslownyc.com/late-night-bar-nyc/] in New York City. With its vibrant atmosphere, exciting entertainment options, delicious food and drinks, and lively events, The Winslow offers an unforgettable nightlife experience.
"We wanted to create a place in NYC where people could truly let loose and have an amazing time," said Mark Tafoya,…
Desperate Puppy Seeks Rescue Before It’s Too Late!
FOR IMMEDIATE RELEASE
Tucson AZ, December 14th, 2021
The StarBarksCoffee.com rescue team was recently assaulted and threatened with being shot for assisting an abused, entangled puppy.
This Video of a neglected puppy desperately seeking rescue from a mentally unstable and violently aggressive owner was taken recently at an RV park in Texas during our annual "Journey Across America" in support of Animal Welfare.
We've contacted Texas authorities, but the Sheriff’s Department informed us the…
Transform your Traditional Businesses Before Its Too Late
Mob Inspire, an app development company has disrupted many industries by providing innovative software solutions to traditional businesses. We understand the rapidly changing tech environment and therefore equipt ourselves with those skills and tech tools which enable us to deal with challenging situations efficiently.
Mob Inspire takes the leverage of the latest tech trends like Blockchain, IoT and Cloud to deliver high-end products to its clients. The popularity…
Late-Night Treats for Late-Night Peeps
WHAT: La Motta’s, the neighborhood favorite in Boston’s SoWa District, is rolling out the late-night red carpet for its hospitality industry folks and friends, with Chef de Cuisine Justin Winter’s creative twists on after-hours snacks. Available every Sunday - Thursday from 10:00PM to last call, La Motta’s is the neighborhood joint for a late-night bash with flavorful bites and brews.
Launching Sunday, February 26th, 2017, guests can expect flavorful options…
Late payment – the hidden challenge facing Europe's businesses
A recent Europe-wide business survey has revealed no improvement in the pressure on European businesses from customers’ late payments, with 55 per cent of businesses across Europe reporting late payments resulting in loss of income, 63 per cent claiming additional pressures on liquidity, and 50 per cent citing late payments as having a direct impact on company growth.
In the Republic of Ireland, 47 per cent of businesses surveyed claimed…
Construction in Bulgaria to stabilise in late 2011
In the coming years Bulgaria's construction sector will start to grow slowly following the hard years of the economic slowdown, although no spectacular changes are expected in the short run. After substantial restructuring of the sector moderate construction market recovery in the period 2012-2013 is expected. Until 2015 the sector will grow on the back of the large-scale infrastructure projects related to EU funds.
According to the report “Construction sector in…
